title: Pulmonary capillary leak syndrome as a result of OKT-3 therapy.
authors: Department of Anesthesiology, Rush Medical College, Chicago, Illinois, USA. Vijay_thillainathan@rush.edu
authors: Vijay
authors: V
authors: Thillainathan
authors: Mira
authors: M
authors: Loh-Trivedi
authors: Arvind
authors: A
authors: Rajagopal
mesh_terms: D000328:Adult; D019559:Capillary Leak Syndrome / Q000139:chemically induced*; D003928:Diabetic Nephropathies / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000150:complications; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000379:methods; D008297:Male; D016853:Muromonab-CD3 / Q000009:adverse effects* / Q000627:therapeutic use; D012720:Severity of Illness Index; D018746:Systemic Inflammatory Response Syndrome / Q000139:chemically induced*
chemical_list: D007155:Immunologic Factors; D016853:Muromonab-CD3